SHALBY · Healthcare · Medical Care Facilities
Composite scorecard: 21/100 — Quality 31 · Valuation 8 · Momentum 21
| Share price | ₹164.88 |
| Market cap | ₹1,841 Cr |
| P/E ratio | 53.1 |
| P/B ratio | 1.8 |
| ROE | 34.8% |
| ROCE | 7.9% |
| Book value | ₹94.39 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,141 Cr | ₹35 Cr | 13.0% |
| 2025 | ₹1,087 Cr | ₹2 Cr | 12.0% |
| 2024 | ₹934 Cr | ₹84 Cr | 19.0% |
| 2023 | ₹805 Cr | ₹68 Cr | 17.0% |
| 2022 | ₹699 Cr | ₹54 Cr | 17.0% |
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; de